logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (v) New inpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates5.340.631.412.84.72.81.41.022.12711194
Cocaine6.833.525.619.29.42.62.30.823.226661
Stimulants15.855.818.75.62.60.80.60.219.1107953
Hypnotics and sedatives7.419.913.58.913.17.86.722.732.5282141
Hallucinogens16.750.033.30.00.00.00.00.018.564
Volatile substances45.148.14.91.20.00.00.00.616.31629
Cannabis 35.043.411.75.22.41.30.60.318.11167129
Other substances 7.630.412.711.47.63.87.619.029.479126
Total14.642.822.99.74.42.31.42.021.25752717

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY, LV,HU, AT, RO, SK, FI, SE, HR, TR 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010